Quick Answer
TAKEDA PHARMACEUTICAL CO LTD reported Total Assets of $14.25 trillion for fiscal year 2025.
TAKEDA PHARMACEUTICAL CO LTD — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $14.25T -5.7% |
$15.11T +8.2% |
$13.96T +5.9% |
$13.18T +2.1% |
$12.91T +0.7% |
$12.82T -7.0% |
| R&D Expense | $730.23B +0.0% |
$729.92B +15.3% |
$633.33B +20.4% |
$526.09B +15.4% |
$455.83B -7.4% |
$492.38B +33.7% |
- TAKEDA PHARMACEUTICAL CO LTD reported Total Assets of $14.25 trillion for fiscal year 2025.
- TAKEDA PHARMACEUTICAL CO LTD showed a decrease of -5.7% in Total Assets compared to the prior fiscal year.
- TAKEDA PHARMACEUTICAL CO LTD reported R&D Expense of $730.23 billion for fiscal year 2025.
- TAKEDA PHARMACEUTICAL CO LTD showed an increase of +0.0% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: